Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform

Product News   Jul 05, 2017

 
Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Data Integrity for Endotoxin Testing – New FAQs Released to the QC Insider™ Toolbox

Product News

Lonza announces new FAQ Tech Tip, Data Integrity for Endotoxin Testing, to assist QC professionals who are testing bacterial endotoxin.

READ MORE

Advancing Biopsy Storage with Automation-Friendly Tubes

Product News

Micronic releases new and secure biopsy storage products to standardize and automate the handling and storage of tissue samples.

READ MORE

BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System

Product News

BD announces it has received clearance from the U.S. Food and Drug Administration (FDA) for its flow cytometer system which will help asses immune deficiency in patients.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE